Dermatology Case 2:
Download
Report
Transcript Dermatology Case 2:
Erythema Multiforme
an acute, self-limiting, inflammatory skin eruption.
Most common cause is Herpes Simplex
Occurs in response to medications, infections
Medications include:
Barbiturates
Penicillins
Phenytoin
Sulfonamides
Infections include:
Herpes simplex
Mycoplasma
Erythema
Multiforme
Data
EG 43 y/o F
Begin as sharply marginated,
erythematous ill-defined
(brief
description
of pathology)
erythematous
macules, which
become
asymptomatic patches
raised, edematous papules over 24 to
(epidemiology,
incidence, etc.) (upper extremities, with
48 hours
tingling sensation,
“target” or “iris” lesion with 3 zones –
numbness of the hands)
central dusky purpura; an elevated,
into multiple
edematous, pale ring; and surrounding
erythematous to skinmacular erythema
colored plaques and
nodules 1.5x 3.5 to 2.0 x
Age of Predilection
4.0 cm (malar area, helix
Young adults
of ears, upper extremities,
thighs)
Site of predilection
(+) leonine facies
dorsal hands, dorsal feet, extensor
limbs, elbows and knees, and
(-) madarosis
Lesion
Patient’s
palms and soles
There are two types of EM:
EM minor and EM major.
EM minor comprises nearly 70% of the cases.
Most cases of EM minor resolve in one to three
weeks
EM major might take three to six weeks to resolve.
Recurrences are more commonly seen in EM minor,
but are rare in EM major.
Traditionally, Stevens- Johnson syndrome (SJS) and
toxic epidermal necrolysis (TEN) were included in
the same spectrum as EM.
EM MINOR
Most patients with EM minor present with new-
onset mucocutaneous lesions which are usually
symmetrical and rapidly progressing in nature.
These lesions may be pruritic or may be associated
with a burning sensation.
EM MAJOR
EM major is usually preceded by prodromal
symptoms such as fatigue, fever, headaches, and
myalgias.
These symptoms can appear up to two weeks prior to
the mucocutaneous manifestations.
Oral mucosal involvement may lead to difficulty in
drinking and eating.
Ocular involvement may lead to complaints of
redness, discharge and ocular pain.
Treatment
Prevention is cornerstone of treatment if HSV can be
demonstrated as the trigger.
Antiherpetic antibiotic